[breadcrumb_custom]

NRX Pharmaceuticals Inc (NASDAQ: NRXP) Surprised Bears, Looks Healthy Going Forward.

In the last trading session, 2.24 million NRX Pharmaceuticals Inc (NASDAQ:NRXP) shares changed hands as the company’s beta touched 1.06. With the company’s per share price at $0.51 changed hands at $0.05 or 10.34% during last session, the market valuation stood at $43.61M. NRXP’s last price was a discount, traded about -135.29% off its 52-week high of $1.20. The share price had its 52-week low at $0.22, which suggests the last value was 56.86% up since then. When we look at NRX Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 0.62 million shares, with the 3-month average coming to 2.48.

NRX Pharmaceuticals Inc (NASDAQ:NRXP) trade information

Instantly NRXP was in green as seen at the end of in last trading. With action 35.09%, the performance over the past five days has been green. The jump to weekly highs of 0.5299 added 10.34% to the stock’s daily price. The company’s shares are showing year-to-date upside of 11.30%, with the 5-day performance at 35.09% in the green. However, in the 30-day time frame, NRX Pharmaceuticals Inc (NASDAQ:NRXP) is 14.67% up. Looking at the short shares, we see there were 2.87 million shares sold at short interest cover period of 5.4 days.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

NRX Pharmaceuticals Inc (NRXP) estimates and forecasts

Data shows that the NRX Pharmaceuticals Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 65.16% over the past 6 months, a 31.15% in annual growth rate that is considerably higher than the industry average of 11.60%. Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2024 revenue estimates. The rating firms predict current quarter revenue for NRX Pharmaceuticals Inc will rise 56.20%, while the growth in revenue is estimated to hit 50.00% for the next quarter.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -120.49%. The 2024 estimates are for NRX Pharmaceuticals Inc earnings to increase by 38.80%.

NRX Pharmaceuticals Inc (NASDAQ:NRXP)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 33.95% of NRX Pharmaceuticals Inc shares while 5.56% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 8.43%. There are 5.56% institutions holding the NRX Pharmaceuticals Inc stock share, with Armistice Capital, LLC the top institutional holder. As of Jun 29, 2023, the company held 6.90% of the shares, roughly 5.64 million NRXP shares worth $2.73 million.

Vanguard Group Inc holds the second largest percentage of outstanding shares, with 1.81% or 1.48 million shares worth $0.71 million as of Jun 29, 2023.

Among Mutual Funds, the top two as of Jun 29, 2023 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. With 0.98 million shares estimated at $0.47 million under it, the former controlled 1.20% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.55% of the shares, roughly 0.45 million shares worth around $0.22 million.

On Key

Related Posts